secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0001213900-24-081531
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive Therapeutics regains compliance with Nasdaq minimum market value requirement
--------------------------------------------------------------------------------

- Nasdaq confirmed compliance with Listing Rule 5550(b)(2) on Sept 24, 2024 after market value exceeded $35M for 10 consecutive days.
- Market value was above $35M from Sept 10 to Sept 23, 2024, regaining compliance.
- Company had previously received a non-compliance notice on July 11, 2024 for failing to meet the minimum market value.
- Removes immediate risk of delisting from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024081531/0001213900-24-081531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024081531/ea0215583-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-081531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer